Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Free Cash Flow (2017 - 2025)

Purple Biotech has reported Free Cash Flow over the past 6 years, most recently at -$4.3 million for Q4 2022.

  • Quarterly Free Cash Flow fell 20.61% to -$4.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$16.8 million through Dec 2022, down 13.59% year-over-year, with the annual reading at -$5.7 million for FY2025, 60.61% up from the prior year.
  • Free Cash Flow was -$4.3 million for Q4 2022 at Purple Biotech, down from -$3.6 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$2.9 million in Q3 2021 and troughed at -$6.6 million in Q4 2020.
  • The 5-year median for Free Cash Flow is -$3.7 million (2022), against an average of -$4.2 million.
  • Year-over-year, Free Cash Flow crashed 98.61% in 2020 and then surged 46.16% in 2021.
  • A 5-year view of Free Cash Flow shows it stood at -$5.0 million in 2018, then surged by 33.67% to -$3.3 million in 2019, then crashed by 98.61% to -$6.6 million in 2020, then surged by 46.16% to -$3.5 million in 2021, then decreased by 20.61% to -$4.3 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Free Cash Flow are -$4.3 million (Q4 2022), -$3.6 million (Q3 2022), and -$3.7 million (Q2 2022).